Skip to content

Therapeutic Recovery of Upper Extremity Motor Function After Stroke by Thermomagnetic Stimulation

Therapeutic Recovery of Upper Extremity Motor Function After Stroke by Thermomagnetic Stimulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016600
Enrollment
Unknown
Registered
2018-06-11
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

therapy group:iTBS on the basis of conventional rehabilitation therapy.

Sponsors

the First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) It accords with the World Health Organization (WHO) definition of stroke in the 1970s, that is, "a series of rapidly progressing clinical symptoms caused by local or global brain dysfunction caused by vascular factors, lasting = 24 hours or Causes death. Including cerebral infarction, intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and providing imaging data (CT or MRI); (2) for the first time, Unilateral morbidity, duration of disease 1-6 months after stroke, stable progression-free; (3) no other neurological disease; (4) severe dyskinesia in affected upper limb: Fugl-Meyer upper limb motor function assessment <33 points; (5) The vital signs are stable and the consciousness is clear; (6) The patients are voluntarily treated with the treatment group or the control group, iTBS cooperates with conventional physical rehabilitation therapy or simply performs conventional physical rehabilitation therapy, and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Subjects with hypertonia in the affected limb (Ashworth grade 4-5); (2) Complications associated with loss of function (eg heart, lung, kidney) or failure; (3) Pregnant women; (4) In vivo There are metal implants in pacemakers, cochlear implants, drug pumps, or affected limbs; (5) deep vein and arterial venous thrombosis in affected upper limbs; (6) unstable fractures in affected upper limbs; (7) severe depression and Patients with mental illness (HAMA <21 points, HAMD <35 points).

Design outcomes

Primary

MeasureTime frame
Surface electromyography root mean square;upper extremity Fugl-Meyer Assessment (FMA);

Secondary

MeasureTime frame
Barthel index;

Countries

China

Contacts

Public ContactYuewen Ma

the First Hospital of China Medical University

yuewen-m@126.com+86 13998881093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026